TY - JOUR
T1 - Comparative efficacy of digitally assisted interventions for glycated haemoglobin levels among patients with type 2 diabetes
T2 - A systematic review and component network Meta-Analysis
AU - Romadlon, Debby Syahru
AU - Tu, Yu Kang
AU - Chen, Yang Ching
AU - Hasan, Faizul
AU - Chiu, Hsiao Yean
N1 - Publisher Copyright:
© 2023 John Wiley & Sons Ltd.
PY - 2023/11
Y1 - 2023/11
N2 - Aims: To compare the efficacy of digitally assisted interventions on the glycated haemoglobin (HbA1c) levels of patients with type 2 diabetes by performing a systematic review, network meta-analysis and component network meta-analysis. Methods: Six databases were searched to identify eligible articles from the inception of each database until 17 March 2023. We included randomized controlled trials evaluating HbA1c levels. Data were pooled with a random-effects model under a frequentist framework. The evidence certainty was assessed using Confidence in Network MetaAnalysis (CINeMA). The PROSPERO registration number was CRD42021283815. Results: In total, 75 trials involving 9764 participants were included. Results from standard network meta-analyses of 17 interventions revealed that compared with standard care, a mobile application (MA) combined with a professional education programme and peer support education (PSE; −1.98, 95% confidence interval = −2.90 to −1.06, CINeMA score: moderate to high) significantly reduced HbA1c levels. The component analysis found that PSE (−1.50, −2.36 to −0.64), SMS (−0.33, −0.56 to −0.11), MA (−0.30, −0.56 to −0.04) and telephone calls (−0.30, −0.53 to −0.06) most effectively reduced HbA1c levels among patients with type 2 diabetes. Conclusions: SMS and MA are the optimal digitally assisted interventions for reducing HbA1c levels. Educators can integrate digitally assisted interventions complemented by educational programmes, particularly MA combined with professional education programme and PSE, into daily care to control HbA1c. The limitations of included trials include a lack of information on allocation concealment and blinding and the fact that long-term follow-up effects were not investigated.
AB - Aims: To compare the efficacy of digitally assisted interventions on the glycated haemoglobin (HbA1c) levels of patients with type 2 diabetes by performing a systematic review, network meta-analysis and component network meta-analysis. Methods: Six databases were searched to identify eligible articles from the inception of each database until 17 March 2023. We included randomized controlled trials evaluating HbA1c levels. Data were pooled with a random-effects model under a frequentist framework. The evidence certainty was assessed using Confidence in Network MetaAnalysis (CINeMA). The PROSPERO registration number was CRD42021283815. Results: In total, 75 trials involving 9764 participants were included. Results from standard network meta-analyses of 17 interventions revealed that compared with standard care, a mobile application (MA) combined with a professional education programme and peer support education (PSE; −1.98, 95% confidence interval = −2.90 to −1.06, CINeMA score: moderate to high) significantly reduced HbA1c levels. The component analysis found that PSE (−1.50, −2.36 to −0.64), SMS (−0.33, −0.56 to −0.11), MA (−0.30, −0.56 to −0.04) and telephone calls (−0.30, −0.53 to −0.06) most effectively reduced HbA1c levels among patients with type 2 diabetes. Conclusions: SMS and MA are the optimal digitally assisted interventions for reducing HbA1c levels. Educators can integrate digitally assisted interventions complemented by educational programmes, particularly MA combined with professional education programme and PSE, into daily care to control HbA1c. The limitations of included trials include a lack of information on allocation concealment and blinding and the fact that long-term follow-up effects were not investigated.
KW - component network meta-analysis
KW - digital assisted intervention
KW - HbA1c
KW - type 2 diabetes
UR - http://www.scopus.com/inward/record.url?scp=85166427007&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85166427007&partnerID=8YFLogxK
U2 - 10.1111/dom.15227
DO - 10.1111/dom.15227
M3 - Article
C2 - 37519284
AN - SCOPUS:85166427007
SN - 1462-8902
VL - 25
SP - 3279
EP - 3289
JO - Diabetes, Obesity and Metabolism
JF - Diabetes, Obesity and Metabolism
IS - 11
ER -